Bayer's Monsanto division is making headlines with a bold offer of $7.25 billion to settle lawsuits concerning Roundup and its alleged link...

Bayer has eliminated approximately 12,000 full-time positions as part of its restructuring efforts aimed at streamlining operations and red...

European shares were marginally higher on Wednesday as robust China data lifted miners, while an overnight Wall Street rally amid persistin...

Aspartame, used in products from Coca-Cola diet sodas to Mars' Extra chewing gum and some Snapple drinks, will be listed in July as "possib...

The artificial sweetener aspartame is set to be declared a possible carcinogen by the International Agency for Research on Cancer (IARC), a...

Leading gains among sectors, the oil & gas sector rose 2.1 per cent, while automakers, banks and travel & leisure rose between 1.5 per cent...

A look at what some of the key indicators are suggesting for Friday’s market action.

The pan-European STOXX 600 fell 1.1% by 0717 GMT, led lower by travel & leisure, bank and oil & gas stocks.

Bayer, which is fighting claims its weedkiller Roundup causes cancer, said its Chairman Werner Wenning was stepping down because the drugs ...

Bayer raised the objection against Natco’s brand launched under the name Regonat alleging infringement of its patent rights.

Following eight weeks of trial proceedings, the San Francisco jury ordered Monsanto to pay USD 250 million in punitive damages along with c...

Their long association and huge cache of shares make them very influential on D-Street as promoters dread their unwavering gaze.

The petition exposes the weak enforcement of an important statutory provision, Form 27, which discloses patent data of a company.

Despite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...

It would safeguard India's ability to export drugs made under compulsory licences issued by a third country.